CVE-2024-54486

Description

The issue was addressed with improved checks. This issue is fixed in iPadOS 17.7.3, watchOS 11.2, visionOS 2.2, tvOS 18.2, macOS Sequoia 15.2, iOS 18.2 and iPadOS 18.2, macOS Ventura 13.7.2, macOS Sonoma 14.7.2. Processing a maliciously crafted font may result in the disclosure of process memory.

6.5
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.13%
Vendor Advisory apple.com Vendor Advisory apple.com Vendor Advisory apple.com Vendor Advisory apple.com Vendor Advisory apple.com Vendor Advisory apple.com Vendor Advisory apple.com Vendor Advisory apple.com
Affected: Apple tvOS
Affected: Apple visionOS
Affected: Apple macOS
Affected: Apple macOS
Affected: Apple watchOS
Affected: Apple iPadOS
Affected: Apple iOS and iPadOS
Affected: Apple macOS
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-54486?
CVE-2024-54486 has been scored as a medium severity vulnerability.
How to fix CVE-2024-54486?
To fix CVE-2024-54486, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-54486 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-54486 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-54486?
CVE-2024-54486 affects Apple tvOS, Apple visionOS, Apple macOS, Apple macOS, Apple watchOS, Apple iPadOS, Apple iOS and iPadOS, Apple macOS.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.